PharmaNet Development Group, Inc., a global provider of drug development services to pharmaceutical, biotechnology, generic drug and medical device companies, has announced a strategic collaboration with Abacus International, one of the largest independent health economic consultancies in Europe. The strategic collaboration builds on the organizations’ common purpose of supporting the development of research-based evidence throughout the drug/device lifecycle to document a product’s clinical and economic value. PharmaNet brings to the collaboration its industry leading experience in the design and implementation of clinical trials and prospective “real world” research studies while Abacus provides focused expertise in health economics, health technology assessment and market access solutions.
“The collaboration will allow PharmaNet and Abacus to support clients in documenting the clinical and economic value of products throughout the entire development process,” commented Jeff Trotter, Executive Vice President, Phase IV Development, PharmaNet Development Group.
Simon Howard, Managing Director, Abacus International, added, “Collaborating with PharmaNet will enable us to blend our expertise and understanding of the European Health Technology Assessment (HTA) landscape with PharmaNet’s capabilities in the design and implementation of “real world” research programs that are increasingly demanded by key stakeholders.”
In the design and deployment of many patient registries, the organizations will draw on Abacus’s e-registry management system web-based software, thereby equipping clients with a full array of services and experience in project management, site management and monitoring, data management and analysis and communications.
